{
    "eid": "2-s2.0-85142941189",
    "title": "Weight change with integrase strand transfer inhibitors among virally suppressed Thai people living with HIV",
    "cover-date": "2022-12-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Microbiology (medical)",
            "@code": "2726",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pharmacology (medical)",
            "@code": "2736",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Infectious Diseases",
            "@code": "2725",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [],
    "authors": [
        "Win Min Han",
        "Stephen J. Kerr",
        "Anchalee Avihingsanon",
        "David C. Boettiger"
    ],
    "citedby-count": 0,
    "ref-count": 22,
    "ref-list": [
        "Global burden of atherosclerotic cardiovascular disease in people living with HIV",
        "Metabolic disease in HIV infection",
        "Weight gain at 3 months of antiretroviral therapy is strongly associated with survival: evidence from two developing countries",
        "Weight change after antiretroviral therapy and mortality",
        "Weight gain following initiation of antiretroviral therapy: risk factors in randomized comparative clinical trials",
        "Weight gain and incident diabetes among HIV-infected veterans initiating antiretroviral therapy compared with uninfected individuals",
        "Brief report: weight gain in persons with HIV switched from efavirenz-based to integrase strand transfer inhibitor-based regimens",
        "Dolutegravir plus two different prodrugs of tenofovir to treat HIV",
        "Pharmacogenomics in Asian subpopulations and impacts on commonly prescribed medications",
        "No overall change in the rate of weight gain after switching to an integrase-inhibitor in virologically suppressed adults with HIV",
        "Weight gain: a possible side effect of all antiretrovirals",
        "A new equation to estimate glomerular filtration rate",
        "Long-term weight gain after initiating combination antiretroviral therapy in treatment-na\u00efve Asian people living with human immunodeficiency virus",
        "Risk factors for weight gain following switch to integrase inhibitor-based antiretroviral therapy",
        "HIV Viral suppression trends over time among HIV-infected patients receiving care in the United States, 1997 to 2015: a cohort study",
        "Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380-1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial",
        "Brief report: weight gain following ART initiation in ART-na\u00efve people living with HIV in the current treatment era",
        "Greater weight gain in treatment-naive persons starting dolutegravir-based antiretroviral therapy",
        "Weight change following antiretroviral therapy switch in people with viral suppression: pooled data from randomized clinical trials",
        "The impact of weight gain during HIV treatment on risk of pre-diabetes, diabetes mellitus, cardiovascular disease, and mortality",
        "Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium",
        "Excess weight gain with integrase inhibitors and tenofovir alafenamide: what is the mechanism and does it matter?"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Kensington",
            "@id": "60026655",
            "affilname": "The Kirby Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026655",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "San Francisco",
            "@id": "60023691",
            "affilname": "University of California, San Francisco",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023691",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60016965",
            "affilname": "The HIV Netherlands Australia Thailand Research Collaboration",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016965",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "National Health and Medical Research Council"
    ]
}